Integrated Biopharma Inc SEC filings INBP
Integrated Biopharma Inc has 557 filings in SEC EDGAR's recent list, going back to Nov 21, 1996. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 8, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (results of operations). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Filing | Feb 16, 2016 | Feb 16, 2016 |
| NT 10-Q | Filing | Feb 14, 2013 | Feb 14, 2013 |
| NT 10-Q | Filing | Nov 14, 2012 | Nov 12, 2012 |
| NT 10-K | Filing | Sep 28, 2012 | Sep 28, 2012 |
| D | Filing | Jul 11, 2012 | — |
| NT 10-Q | Filing | May 16, 2012 | May 15, 2012 |
| NT 10-Q | Filing | Feb 14, 2012 | Feb 14, 2012 |
| NT 10-Q | Filing | Nov 14, 2011 | Nov 14, 2011 |
| NT 10-K | Filing | Sep 28, 2011 | Sep 28, 2011 |
| NT 10-Q | Filing | May 16, 2011 | May 16, 2011 |
| NT 10-Q | Filing | May 17, 2010 | May 17, 2010 |
| NT 10-Q | Filing | Nov 16, 2009 | Nov 16, 2009 |
| DEFR14A | Filing | Nov 2, 2009 | — |
| NT 10-K | Filing | Sep 28, 2009 | Jun 30, 2009 |
| NT 10-Q | Filing | May 15, 2009 | Mar 31, 2009 |
| 25 | Filing | Apr 13, 2009 | — |
| NT 10-Q | Filing | Feb 17, 2009 | Dec 31, 2008 |
| DEFR14A | Filing | Nov 5, 2008 | — |
| NT 10-K | Filing | Sep 29, 2008 | Jun 30, 2008 |
| UPLOAD | Letter from the SEC | Aug 4, 2008 | — |
| PRER14C | Filing | Jul 17, 2008 | — |
| PRER14C | Filing | Jul 11, 2008 | — |
| PRER14C | Filing | Jun 18, 2008 | — |
| NT 10-Q | Filing | May 16, 2008 | Mar 31, 2008 |
| PRER14C | Filing | May 12, 2008 | — |
| EFFECT | Filing | May 2, 2008 | — |
| CORRESP | Letter to the SEC | Apr 30, 2008 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2008 | — |
| PRER14C | Integrated biopharma, inc. | Apr 2, 2008 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2008 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2008 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2008 | — |
| REGDEX | Auto-generated paper document | Mar 7, 2008 | — |
| NT 10-Q | Integrated biopharma, inc. | Feb 14, 2008 | Dec 31, 2007 |
| NT 10-Q | Integrated biopharma, inc. | Nov 15, 2007 | Sep 30, 2007 |
| RW | Integrated biopharma, inc. | Aug 23, 2007 | — |
| EFFECT | Filing | Jul 11, 2007 | — |
| CERTNAS | Auto-generated paper document | Feb 6, 2007 | — |
| 8-A12B | Form 8-a - integrated biopharma, inc. | Feb 5, 2007 | — |
| 25 | Integrated biopharma, inc. | Feb 5, 2007 | — |
| 10KSB | Integrated biopharma, inc. - form 10-ksb | Sep 28, 2005 | Jun 30, 2005 |
| 10QSB | Integrated biopharma, inc. | May 16, 2005 | Mar 31, 2005 |
| 10QSB | Integrated biopharma, inc. | Feb 14, 2005 | Dec 31, 2004 |
| CORRESP | Letter to the SEC | Feb 10, 2005 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2005 | — |
| 10QSB | Integrated biopharma, inc. | Nov 12, 2004 | Sep 30, 2004 |
| 10KSB/A | Integrated biopharma, inc. | Nov 10, 2004 | Nov 9, 2004 |
| 10QSB | 10-qsb march 31 2004 - integrated biopharma, inc. | May 14, 2004 | Mar 31, 2004 |
| REGDEX | Auto-generated paper document | May 11, 2004 | — |
| REGDEX | Auto-generated paper document | May 5, 2004 | — |
| 10QSB | Integrated biopharma, inc. - december 31, 2003 | Feb 13, 2004 | Dec 31, 2003 |
| 10QSB | Integrated biopharma, inc. - september 30, 2003 | Nov 14, 2003 | Sep 30, 2003 |
| 10KSB | Filing | Sep 29, 2003 | Jun 30, 2003 |
| 10QSB/A | Integrated biopharma, inc. | Sep 26, 2003 | Mar 31, 2003 |
| 10QSB | Quarterly report | May 7, 2003 | Mar 31, 2003 |
| CERTAMX | Auto-generated paper document | Apr 16, 2003 | — |
| 8-A12B | Integrated health technologies, inc. | Apr 15, 2003 | — |
| 10QSB | Form 10qsb | Feb 4, 2003 | Dec 31, 2002 |
| 10QSB | Filing | Nov 12, 2002 | Sep 30, 2002 |
| 10KSB | Quarterly report | Sep 12, 2002 | Jun 30, 2002 |
| 10QSB | Form 10qsb | May 14, 2002 | Mar 31, 2002 |
| 10QSB | Form 10-qsb | Feb 12, 2002 | Dec 31, 2001 |
| 10QSB | Quarterly report | Nov 14, 2001 | Sep 30, 2001 |
| DEFR14A | Form defr14a | Nov 9, 2001 | — |
| 10KSB | 10-ksb | Sep 25, 2001 | Jun 30, 2001 |
| 10QSB | Quarterly report | May 14, 2001 | Mar 31, 2001 |
| 10QSB | Form 10qsb | Feb 13, 2001 | Dec 31, 2000 |
| 10QSB | Form 10-qsb | Nov 14, 2000 | Sep 30, 2000 |
| 10KSB | Annual report | Sep 28, 2000 | Jun 30, 2000 |
| 10QSB | Quarterly report | May 9, 2000 | Mar 31, 2000 |
| 10QSB | Quarterly report | Feb 10, 2000 | Dec 31, 1999 |
| 10QSB | Quarterly report | Nov 8, 1999 | Sep 30, 1999 |
| 10KSB | Form 10-ksb | Oct 1, 1999 | Jun 30, 1999 |
| NT 10-K | Notification of late filing | Sep 29, 1999 | Jun 30, 1999 |
| 10QSB | Quarterly report | May 13, 1999 | Mar 31, 1999 |
| 10QSB | Filing | Feb 10, 1999 | Dec 31, 1998 |
| 10QSB | Filing | Nov 12, 1998 | Sep 30, 1998 |
| N-30D | Annual report | Nov 3, 1998 | Jun 30, 1998 |
| 10KSB | Filing | Sep 24, 1998 | Jun 30, 1998 |
| 10QSB | 10 qsb | May 12, 1998 | Mar 31, 1998 |
| 10QSB | 10 - qsb | Feb 9, 1998 | Dec 31, 1997 |
| 10QSB | Filing | Nov 14, 1997 | Sep 30, 1997 |
| 10KSB | Filing | Sep 29, 1997 | Jun 30, 1997 |
| 10QSB | Filing | May 2, 1997 | Mar 31, 1997 |
| 10QSB | 1'st qtr 10 -qsb | Dec 9, 1996 | Sep 30, 1996 |
| 8-A12G/A | Chem international, inc. | Nov 21, 1996 | — |
| 8-A12G | Chem international, inc. | Nov 21, 1996 | — |
Showing 87 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INBP (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Hillside, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1016504
- Former names
- INTEGRATED HEALTH TECHNOLOGIES INC (until Apr 16, 2003); CHEM INTERNATIONAL INC (until May 14, 2002)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.